PARP1 and ovarian dysfunction: Although the use of PARP-1 inhibitors can have the efficacy for the treatment of an inflammatory-induced tissue injury[14,18,28,29], the inhibitory effects of this enzyme on LPS-induced ovarian dysfunction remain unclear.